Chain Bridge Bancorp, Inc. is a bank holding company for Chain Bridge Bank, N.A., specializing in services for political organizations. The filing highlights risks related to deposit seasonality following the November 2026 elections and the company's dual-class stock structure controlled by the Fitzgerald Family.
Bionano Genomics reported total revenue of $8.28 million for the third quarter of 2026, a 12% increase year-over-year, while narrowing its quarterly net loss to $6.45 million compared to $8.50 million in 2025. The company's cash position remains tight, with total cash, cash equivalents, and investments decreasing significantly from $19.27 million at the end of 2025 to $8.17 million as of September 30, 2026.
Electromed, Inc. reported net revenues of $18.7 million for the quarter ended September 30, 2026, a 10.6% increase over the prior year, driven primarily by growth in the homecare market. Net income rose to $2.8 million from $2.1 million, while the company significantly increased its common stock repurchases to $4.3 million during the period.
Carlsmed, Inc. reported revenue of $56.6 million for the nine months ended September 30, 2026, a significant increase from $35.3 million in the prior year period. Despite the revenue growth, the company recorded a net loss of $31.5 million for the first nine months of 2026 as operating expenses, particularly in sales, marketing, and general administration, increased substantially.
Kura Oncology reported total revenue of $22.8 million for Q3 2026, driven by the introduction of $13.9 million in product revenue. Despite this, the company recorded a net loss of $70.2 million for the quarter and $211.9 million for the first nine months of 2026, with total stockholders' equity declining significantly to $18.0 million from $174.1 million at year-end 2025.
Atara Biotherapeutics reported Q3 2026 financial results, highlighting a significant 83% year-over-year reduction in operating expenses and a net loss of $2.2 million. The company is focused on the FDA's March 31, 2027, PDUFA date for tab-cel, which if approved would trigger a $31 million milestone payment from Pierre Fabre Laboratories.
“The resubmission of the tab-cel BLA was an important milestone this quarter, and we remain focused on supporting Pierre Fabre Pharmaceuticals (PFP) toward a successful outcome. We continue to believe in tab-cel’s significant commercial potential in the U.S. In parallel, we are taking steps to control expenses with the goal of protecting and maximizing shareholder value while enhancing our strategic flexibility.”
Cokey Nguyen, President and Chief Executive Officer
Intelligent Protection Management Corp. reported Q3 2026 revenue of $11.0 million, a 75% increase year-over-year, driven by strong demand for cybersecurity and cloud infrastructure procurement. The company generated $5.6 million in operating cash flow and noted a 33% increase in core managed services revenue from non-affiliated customers.
Term
Q3 2026
“Financial results for the third quarter of 2026 reflected exceptional customer demand and continued execution of our growth strategy, resulting in total revenue increasing more than 75% to approximately $11.0 million compared to the third quarter of 2025.”
Jason Katz, Chairman and Chief Executive Officer
“Our balance sheet remains strong, providing the financial flexibility necessary to support organic growth initiatives while pursuing strategic opportunities that enhance our long-term growth profile.”
LightPath Technologies reported fiscal 2027 first quarter revenue of $20.8 million, a 38% year-over-year increase driven by a shift toward higher-value cameras and optical assemblies. The company achieved a record order backlog of $132.9 million and generated its fifth consecutive quarter of positive adjusted EBITDA. During the period, the company also completed the sale of its China subsidiary and secured over $30 million in follow-on defense-related orders.
Term
Q1 2027
“Fiscal 2027 is off to a strong start, led by backlog, a key indicator of our expected future revenue trends. New orders significantly outpaced shipments during the first quarter, lifting backlog by $22 million to a record $132.9 million, with approximately $110.8 million of it requested by customers for delivery over the next twelve months.”
Sam Rubin, President and Chief Executive Officer
“The composition of our revenue continues to be more favorable as well. Revenue grew 38% year-over-year to $20.8 million, and assemblies and modules accounted for 51% of the total, up from 40% a year ago. That shift toward higher-value cameras and optical assemblies lifted gross margin to 41.4%, and we generated positive adjusted EBITDA for the fifth consecutive quarter while more than doubling our investment in new product development.”
National CineMedia reported a net loss of $17.2 million for the third quarter of 2026, compared to a net income of $1.6 million in the prior year period, primarily driven by a $36.4 million loss on the re-measurement of the tax receivable agreement. The company significantly expanded its balance sheet through a $271.1 million business acquisition funded by a new $275.0 million term loan facility.
Black Rock Coffee Bar reported Q3 2026 revenue of $66.8 million, a 29.7% increase year-over-year, driven by 5.8% same-store sales growth and 11 new store openings. The company achieved net income of $2.7 million, a significant turnaround from a $16.2 million net loss in the prior year period. Management updated its full-year development target to 40 new store openings while reaffirming its revenue and Adjusted EBITDA guidance.
Term
Q3 2026
“We delivered another exceptional quarter, with revenue increasing 30% and adjusted EBITDA growing 22% year-over-year, reflecting the continued strength of our brand, customer engagement strategy and operating model. Same-store sales accelerated to 5.8%, or 16.6% on a two-year basis, marking our 15th consecutive quarter of positive same-store sales growth, while positive transaction growth reinforced our confidence in the resilience of consumer demand and the momentum we are building across the business.”
Vroom, Inc. reported its third quarter 2026 financial results, highlighting a net loss of $9.8 million and a stockholders' equity position of $91.1 million. The company updated its full-year 2026 guidance, projecting indirect origination volume between $460 million and $485 million and an adjusted net loss of $30 million to $35 million.
Term
Q3 2026
“In the third quarter of 2026, adjusted net loss improved significantly year-over-year as we continue to see the benefits of our rebuilt internal customer scoring model, which was implemented in September 2025. We also continue to make significant investments in our Next-Generation Technology Platform and we are pleased with the rollout of our Next-Generation FastLane dealer portal.”
Tom Shortt, Chief Executive Officer
“During the third quarter, we further strengthened our balance she”
Grayscale Sui Staking ETF reported net assets of $46.076 million as of September 30, 2026, a significant increase from $4.301 million at the end of 2025, driven by $33.7 million in net capital contributions and $8.067 million in net increase from operations. The Trust successfully uplisted to NYSE Arca on February 18, 2026, and began generating staking reward income, which totaled $246,000 for the first nine months of 2026.
Mobile Infrastructure Corp reported a net loss of $2.55 million for the quarter ended September 30, 2026, an improvement from a $6.43 million loss in the prior year period. Total revenues increased slightly to $9.58 million, driven by growth in managed property revenue, while total operating expenses decreased significantly due to lower depreciation and impairment charges.
For the third quarter of 2026, Grove Collaborative reported net revenue of $36.8 million and achieved a small net income of $0.1 million, a significant improvement from the $3.0 million net loss in the prior year period. The company reduced operating expenses across advertising and SG&A, though it continues to carry a total stockholders' deficit of $16.9 million.
Metagenomi Therapeutics, Inc. is an emerging growth company focused on genome editing technology, reporting 37,805,669 shares of common stock outstanding as of November 6, 2026. The filing highlights ongoing research and development programs, preclinical proof-of-concept goals, and risks related to macroeconomic volatility and regulatory developments.
QT Imaging Holdings reported significant revenue growth for the nine months ended September 30, 2026, reaching $21.3 million compared to $10.7 million in 2025. Despite this, the company incurred a net loss of $14.8 million, driven by increased operating expenses and a $8.3 million loss on debt extinguishment and modification.
SenesTech reported record third quarter 2026 revenue of $1.1 million, representing 59% year-over-year growth driven by a 337% surge in e-commerce sales. While gross profit reached a record $796,000 with a 72.6% margin, the company reported a net loss of $2.0 million for the quarter. Operational highlights include the expansion of the B2B sales team and the launch of new assessment and monitoring services for commercial customers.
For the nine months ended September 30, 2026, Grayscale Stellar Lumens Trust reported a net increase in net assets resulting from operations of $2.879 million, driven by $3.313 million in unrealized appreciation despite a net investment loss of $396,000. Total net assets grew to $26.848 million as of September 30, 2026, supported by capital share transactions and an increase in the Principal Market NAV per Share from $16.69 to $18.63.
QumulusAI, Inc. is a non-accelerated filer and emerging growth company that recently transitioned to public reporting, as evidenced by its 2026 filing. The company operates in the GPU-as-a-service and blockchain mining sectors, reporting significant risks including a history of losses, substantial indebtedness, and reliance on a single channel partner for GPU revenue.
For the nine months ended September 30, 2026, New Mountain Private Credit Fund reported total investment income of $144.4 million and net investment income of $71.5 million. The fund experienced significant net realized and unrealized losses totaling $56.2 million, resulting in a net increase in net assets from operations of $15.3 million, a decrease from $38.6 million in the prior year period.
Sky Harbour Group reported Q3 2026 financial results with consolidated revenues increasing 45% year-over-year. The company ended the quarter with $199.4 million in cash and U.S. Treasuries, plus $129.2 million in available capacity under its JP Morgan construction facility. Management also updated leasing progress, noting 92% occupancy at its Miami-Opa Locka campus and 101% economic occupancy at Dallas Addison Phase 1.
Micware Co., Ltd. reported a 3.4% increase in revenue to JPY10,612.7 million for the first half of fiscal year 2027, driven by growth in software-defined vehicle (SDV) projects. While gross profit rose 19.5% due to a shift toward higher-value upstream development, net income decreased 13.5% to JPY612.9 million, primarily due to one-time IPO-related share-based compensation and increased R&D investment in the DynaPlanet platform.
The Grayscale Solana Staking ETF reported a net increase in net assets of $62.576 million for the three months ended September 30, 2026, driven by significant unrealized appreciation. The Trust successfully transitioned to staking operations in 2026, generating $5.559 million in staking reward income year-to-date, while net assets grew to $213.466 million.
Gain Therapeutics reported a net loss of $13.4 million for the nine months ended September 30, 2026, with cash and cash equivalents decreasing to $11.7 million from $20.8 million at year-end 2025. The company highlighted its ongoing reliance on additional financing to support its Magellan™ platform and clinical development programs.
Firefly Aerospace reported Q3 2026 revenue of $110.7 million, a 259% year-over-year increase, driven by a record backlog of $1.7 billion. The company highlighted significant operational progress, including the expansion of its spacecraft cleanroom facility and the signing of major launch and technology contracts with AST SpaceMobile and Lockheed Martin.
Term
Q3 2026
“Firefly’s third quarter reflects the power of our diversified and vertically-integrated business. With five Moon missions running in parallel, Alpha Block II moving toward launch, SciTec executing on critical national security programs, and our strategic deal with AST SpaceMobile, we are converting our pipeline and backlog into results.”
B&G Foods reported total current assets of $772.6 million as of October 3, 2026, compared to $739.8 million at the start of the year. The company is actively exploring the divestiture of its Green Giant and Le Sieur businesses in Canada to reduce long-term debt and improve margins.
Palisade Bio reported a net loss of $34.8 million for the nine months ended September 30, 2026, compared to $7.9 million in the prior year, driven by a significant increase in research and development expenses. The company maintained a cash position of $113.6 million and generated $0.5 million in license revenue during the period.
Fossil Group reported Q3 2026 net sales of $271.2 million, a 0.4% increase, with gross margin expanding significantly by 10.8 percentage points to 59.8%. The company achieved operating income of $25 million and raised its full-year 2026 financial outlook based on strong year-to-date performance and product innovation momentum.
Term
Q3 2026
“Our strong third quarter results reflect momentum across brands, channels and geographies and demonstrate that our product innovation and storytelling is connecting with consumers around the globe.”
Franco Fogliato, CEO
“The three strategic pillars under our turnaround plan are translating to top line growth and accelerating profitability. We are pleased that year-to-date results are outpacing our expectations, supporting an increase in our full year financial outlook on both the top and bottom line.”
National CineMedia reported Q3 2026 financial results, with revenue decreasing 3.2% to $61.4 million and a net loss of $17.2 million. The company completed its acquisition of Captivate during the quarter, expanding its digital screen network to 48,000 across theaters and residential/office properties. Additionally, the company announced the planned retirement of CEO Tom Lesinski.
Term
Q3 2026
“With Captivate now part of NCM, we have significantly expanded our reach, diversified our advertising offerings and created new opportunities to connect brands with highly engaged audiences where they work, live and play. We are encouraged by early fourth-quarter trends across both networks, supported by a strong holiday theatrical slate and growing demand for Captivate’s office and residential inventory. Looking ahead, we remain focused on successfully integrating Captivate, realizing acquisition synergies and reducing leverage to drive sustainable growth and long-term value for our shareholders. As I prepare to retire, I am incredibly proud of what we have accomplished together and confident in NCM's future”
Tom Lesinski, Chief Executive Officer of National CineMedia, Inc.
Dermata Therapeutics transitioned from a prescription R&D focus to a direct-to-consumer skincare brand, launching its first Tome product in August 2026. For the nine months ended September 30, 2026, the company reported a net loss of $7.6 million on initial sales of $74,137, with cash reserves decreasing to approximately $4.8 million.